WGS
GeneDx Holdings Corp.- Healthcare
- Medical - Diagnostics & Research
- $2.54B market cap
Forecast run · Sep 14, 2026Upside rank 571 of 3,136
Model Signal
ForecastQ Daily Probabilities
53.8%
51.2%
30.0%
Analyst Consensus
Recommendation2.09/5 Buy
Last price$85.27
Price target$79.50
Implied move-6.8%
Analysts11
ForecastQ Portfolios
Company Profile
GeneDx Holdings Corp., a genomics company, provides genetic testing services. The company primarily offers pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing, as well as data and information services. It also develops an AI-based platform for next generation sequencing analysis, interpretation, and clinical reporting for rare disease, hereditary risk, and cancer testing. GeneDx Holdings Corp. was founded in 2000 and is headquartered in Stamford, Connecticut.